Report overview
This report aims to provide a comprehensive presentation of the global market for Radioligand Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioligand Therapy. This report contains market size and forecasts of Radioligand Therapy in global, including the following market information:
Global Radioligand Therapy Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Radioligand Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Actinium 225 (Ac-225) Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Radioligand Therapy include Novartis, Advanced Accelerator Applications, Mercy Radiology, POINT Biopharma Global Inc, Fusion Pharma, Telix Pharmaceuticals Ltd, Lantheus Holdings, Inc, Bayer AG and Curium Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Radioligand Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radioligand Therapy Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Radioligand Therapy Market Segment Percentages, by Type, 2022 (%)
Actinium 225 (Ac-225)
Lutetium 177 (Lu-177)
Gallium 68 (Ga-68)
Fluorine 18 (F-18)
Other Radionuclides
Global Radioligand Therapy Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Radioligand Therapy Market Segment Percentages, by Application, 2022 (%)
Neuroendocrine Neoplasms
Prostate Cancer
Global Radioligand Therapy Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Radioligand Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radioligand Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Radioligand Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Advanced Accelerator Applications
Mercy Radiology
POINT Biopharma Global Inc
Fusion Pharma
Telix Pharmaceuticals Ltd
Lantheus Holdings, Inc
Bayer AG
Curium Pharma
Precirix
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radioligand Therapy, market overview.
Chapter 2: Global Radioligand Therapy market size in revenue.
Chapter 3: Detailed analysis of Radioligand Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radioligand Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
